Ikarian Capital’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Ikarian Capital’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-367,112	Closed	-$60K	–	153
2023 Q1	$60K	Buy	+367,112	New	+$70.8K	0.01%	114

Other funds holding RCKTW

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return